NCPA Calls on CMS to Establish PBM Protection for Independent Pharmacies
As Medicare open enrollment begins, the NCPA is urging CMS to facilitate appropriate PBM contracting for pharmacies in the upcoming plan year.
Pharmacist-Led Interventions Improve Hypertension Outcomes in Remote Program
Findings were presented at the American Heart Association's Hypertension Scientific Sessions in Chicago, Illinois.
C Difficile Treatment Shows Positive Results in Phase 2 Study
CRS3123 is a novel, small molecule, antibiotic drug candidate that selectively inhibits 1 form of the bacterial methionyl-tRNA synthetase enzyme and is not affected by resistance to any existing classes of antibiotics.
Major Drug Distributors to Pay $300 Million in Opioid Epidemic Settlements
McKesson, Cardinal Health, and Cencora will share the settlement payment, resolving claims that the companies were significantly involved in fueling the US opioid epidemic.
FDA Clears First Digital Therapeutic for Treatment of Generalized Anxiety Disorder
DaylightRX from Big Health is a digital formulation of cognitive behavioral therapy and is available by prescription only.
FDA Clears New Disposable Insulin Patch Pump for Patients With T1D and T2D
Embecta’s new patch pump offers a larger insulin reservoir to better accommodate for the needs of patients with type 2 diabetes (T2D).
Digital Therapeutic Shows Significant Reduction in Episodic Migraine
Click Therapeutics announced that CT-132 met its primary endpoint in the phase 3 ReMMi-D trial.
Q&A: Turning Old Technology into Something New for Pharmaceutical Storage
Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, explained the current state of his company’s cooling technology and the common trends of temperature control throughout the industry.
Familial Chylomicronemia Syndrome Treatment Shows Positive Results in Phase 3 Trial
Results from the PALISADE study were published in The New England Journal of Medicine.
Positive Topline Data From 31-Valent Pneumococcal Conjugate Vaccine Clinical Study Announced
The vaccine, VAX-31, targets 20 serotypes in common with PCV20, as well as 11 additional serotypes.
After Initial Stumbles, Tolebrutinib Achieves Primary Endpoint in Phase 3 nrSPMS Trial
Results from HERCULES will form the basis for future discussions with global regulatory authorities, according to Sanofi.
FDA Approves Updated Novavax COVID-19 Vaccine
The protein-based vaccine includes a monovalent component corresponding to the Omicron variant JN.1 strain.
Immunization Roundup: Updated COVID-19 Vaccines, Mpox Approval, and More
Catch up on important immunization news from the month of August.
Weekend ICYMI: August 26 to August 30
In case you missed it, this week we had news about COVID-19 and the upcoming respiratory virus season, advancements in clinical trials for ASCVD, the first OTC birth control, and more.
Q&A: How Health Care Providers Can Help Increase COVID-19 Vaccine Uptake
Chijioke Bennett, executive director of clinical development at Novavax, discusses how health care providers can increase awareness around the importance of COVID-19 vaccines.
FDA Approves Expanded Use of ACAM2000 Vaccine for Mpox Amid Public Health Emergency
Emergent BioSolutions has announced that it will donate 50,000 doses of ACAM2000 for potential deployment across affected areas in Central Africa.
Diabetes Roundup: FDA Clears Omnipod 5, Tirzepatide Demonstrates Trial Success, and More
Catch up on important diabetes news from the month of August.
FDA Roundup: Agency Highlights from August 2024
Checkout these important FDA updates from the month of August 2024.
Roflumilast Cream Shows Durable Safety, Efficacy in Children with Atopic Dermatitis
Results from the INTEGUMENT-OLE phase 3 trial showed the therapy was also well-tolerated, with no new safety signals observed during treatment of up to 56 weeks.
Q&A: Opill Ushers in New Era of Access to Birth Control
Stephanie Sober, MD, MSHP, investigator on the pivotal research that supported the prescription-to-OTC switch of Opill, shares insights on how the medicine is reshaping the reproductive landscape.
Psilocybin Mushrooms: A Journey from Ancient Traditions to Modern Clinical Use
As research continues to uncover the potential benefits of psilocybin, pharmacists and other clinicians have an essential role in bridging ancient wisdom with contemporary science.
Investigational Acute Pain Therapy to be Evaluated in Pivotal Phase 3 Trials
Tris Pharma will examine the efficacy and safety of cebranopadol in the ALLEVIATE-1 and ALLEVIATE-2 studies.
Drug Topics Top 10: Most Read Stories From August 2024
Check out this list of our top 10 stories from August 2024.
School Openings After COVID-19 Lockdowns Associated With Increased Psychiatric Emergencies
Researchers addressed the association of COVID-19 pandemic-related school disruptions with children’s incidence of acute psychiatric emergencies.
Free At-Home COVID-19 Test Program Returns as Cases Rise
The government said the tests will “detect current COVID-19 variants and can be used through the end of the year.”
In Depth Perspectives: Importance of Patient Advocacy, PBM Scrutiny, and More
Check out these top featured stories from Drug Topics in August 2024.
Dexcom’s OTC Continuous Glucose Monitor Now Available in US
The Stelo glucose biosensor system is intended for use in adults who do not use insulin or in those without diabetes who wish to better understand how diet and exercise affect blood glucose levels.
High-Dose, Adjuvanted Flu Vaccines Prove More Effective for Older Adults
“While seasonal variation exists, it is expected that seniors will continue to benefit from flu vaccines that are stronger than the traditional standard-dose vaccines,” wrote investigators.
Voices in Pharmacy: August 2024 Expert Interviews
Check out these featured Drug Topics interviews from August 2024.
Weekend ICYMI: August 19 to August 23
In case you missed it, this week we had news about illegal online GLP-1 sales, pharmacy deserts, innovative medication cooling technologies, and more.
